phosphorodithioic acid has been researched along with Malignant Melanoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ager, CR; Curran, MA; Di Francesco, ME; Jones, P; Wei, Z; Zhang, H | 1 |
Amartey, J; Noe, CR; Stessl, M; Winkler, J | 1 |
Apfel, R; Bogdahn, U; Bosserhoff, AK; Fabel, K; Hau, P; Jachimczak, P; Schlingensiepen, KH; Schuler-Thurner, B; Tschertner, I; Wise, P | 1 |
Benimetskaya, L; Colombini, M; Lai, JC; Miller, P; Stein, CA; Tan, W | 1 |
4 other study(ies) available for phosphorodithioic acid and Malignant Melanoma
Article | Year |
---|---|
Discovery of IACS-8803 and IACS-8779, potent agonists of stimulator of interferon genes (STING) with robust systemic antitumor efficacy.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cell Line; Cytosol; Heterocyclic Compounds; Humans; Immunity, Innate; Immunotherapy; Interferon-beta; Melanoma; Melanoma, Experimental; Membrane Proteins; Mice; Nucleotides, Cyclic; Phosphates; Signal Transduction; Tumor Microenvironment | 2019 |
Off-target effects related to the phosphorothioate modification of nucleic acids.
Topics: Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Electrophoresis, Gel, Two-Dimensional; Humans; Intercellular Adhesion Molecule-1; Lactates; Melanoma; Oligonucleotides, Antisense; Phosphates; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; Thionucleotides | 2010 |
Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques.
Topics: Cell Line, Tumor; Cytotoxicity, Immunologic; Extracellular Matrix Proteins; Gene Expression Regulation, Neoplastic; Glioma; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Leukocytes, Mononuclear; Lymphocyte Activation; Melanoma; Neoplasm Proteins; Oligonucleotides, Antisense; Phosphates; Proteins; Recombinant Proteins; Thionucleotides | 2005 |
A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC.
Topics: Base Sequence; Cell Line, Tumor; Cytochromes c; Humans; Ion Channel Gating; Melanoma; Mitochondria; Mitochondrial Membranes; Oligonucleotides; Phosphates; Thionucleotides; Voltage-Dependent Anion Channels | 2006 |